July 27 (Reuters) - Innoviva Inc INVA.O :
* INNOVIVA REPORTS SECOND QUARTER 2022 FINANCIAL RESULTS AND
HIGHLIGHTS RECENT COMPANY PROGRESS
* INNOVIVA - NET CASH AND CASH EQUIVALENTS $283.6 MILLION,
INCLUDING $22.4 MILLION OF ENTASIS' CASH BALANCE, RECEIVABLES
FROM GSK $111.7 MILLION AS OF JUNE 30, 2022
* INNOVIVA INC - QTRLY DILUTED NET INCOME PER SHARE
ATTRIBUTABLE
TO INNOVIVA STOCKHOLDERS $0.05
Source text for Eikon: ID:nBw3zMf8ga
Further company coverage: INVA.O
((Reuters.Briefs@thomsonreuters.com;))